Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib can temporarily improve hair growth in alopecia universalis, but its effectiveness may decrease over time.

TP0427736 may help treat hair loss by blocking a specific protein and promoting hair growth.

Oral JAK inhibitors improved alopecia areata by modulating immune responses and boosting hair growth.

ALRN-6924 may prevent hair loss caused by chemotherapy.

Proteasome inhibitors are promising treatments for various cancers, autoimmune diseases, and other conditions.

Baricitinib effectively improved skin and hair conditions in a patient with alopecia areata and atopic dermatitis.

Short-term treatment with ROCKi increases skin cell growth without changing stem cell features.

Patients with rheumatoid arthritis using tofacitinib had more serious side effects than those with alopecia areata.

Janus kinase inhibitors are effective for severe alopecia areata, promoting hair regrowth.

Valproic acid and crocin together boost cell growth and may help treat nerve injuries.

No single ideal JAK inhibitor for alopecia areata has been determined; JAK3 inhibitors may be promising with fewer side effects.

A woman's hair grew back after she stopped taking the Parkinson's disease medication pramipexole.

Machine learning can predict how well patients with alopecia areata will respond to certain treatments.

Tofacitinib effectively regrows hair in alopecia areata but may need continuous use.

Nilotinib can cause generalized keratosis pilaris.

CEP135 may predict cancer outcomes, and targeting PLK1 could help treat certain sarcomas.

Tofacitinib is effective and safe for treating alopecia areata.

Baricitinib can cause excessive hair growth.

PRF lysates reduce inflammation in cancer cells and boost immune response in healthy oral cells.

Tofacitinib shows promise for treating severe hair loss in adults and teens, with many experiencing regrowth, but hair loss returns when treatment stops.

Baricitinib effectively regrows scalp hair in most people with severe alopecia areata.

Tofacitinib works well for treating alopecia areata, especially when combined with corticosteroids, but is less effective if the disease has lasted over 2 years.

The PRP-like cosmetic with biomimetic peptides is potentially effective and safe for treating alopecia areata.

A3B5 can reduce skin pigmentation and slow melanoma growth.

Certain cancer drugs can cause skin issues like rashes and itching.

Low-dose sorafenib can cause severe facial acne, treatable with topical medication.

JAK inhibitors effectively treat severe alopecia areata with manageable side effects.

The combination of mitoxantrone, etoposide, and prednisolone is effective for treating relapsed lymphoma with manageable side effects.

Topical JAK inhibitors may help treat alopecia universalis by promoting hair regrowth.

Upadacitinib improves life quality for Alopecia Areata patients without worsening skin issues.